id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2024-N-0826-0001,FDA,FDA-2024-N-0826,"Advisory Committee; Genetic Metabolic Diseases Advisory
Committee; Addition to List of Standing Committees",Rule,Final Rule,2024-03-06T05:00:00Z,2024,3,2024-03-06T05:00:00Z,,2024-03-06T14:30:03Z,2024-04751,0,0,09000064864646b9